Kaplan-Meier plot of survival during treatment of rifampicin resistant tuberculosis by ART initiation, from multivariate Cox regression analysis for HIV co-infected patients.

Kaplan Meier curves of the probability of reaching the different end-points according to the PI/r component of the initial cART regimen in 1362 HIV positive LC patients.

Antonella d’Arminio Monforte (2198545)
Alessandro Cozzi-Lepri (195759)
Franco Maggiolo (372561)
Giuliano Rizzardini (103636)
Paolo Emilio Manconi (3162948)
Nicola Gianotti (3162951)
Tiziana Quirino (3162945)
Carmela Pinnetti (782902)
Stefano Rusconi (237803)
Andrea De Luca (132288)
Andrea Antinori (103654)

June 2016

Kaplan Meier curves of the probability of reaching the different end-points according to the PI/r...

Univariate and multivariate analyses to assess associations with rifampicin resistance among all, previously treated, and HIV positive culture positive TB cases.

Helen S. Cox (80991)
Cheryl McDermid (335960)
Virginia Azevedo (335962)
Odelia Muller (359842)
David Coetzee (129367)
John Simpson (359843)
Marinus Barnard (359844)
Gerrit Coetzee (296078)
Gilles van Cutsem (93995)
Eric Goemaere (129370)

February 2013

Univariate and multivariate analyses to assess associations with rifampicin resistance among all,...

Kaplan-Meier survival estimate for HIV-associated TBM patients.

M. Estee Torok (5653990)
Tran Thi Hong Chau (81615)
Pham Phuong Mai (378050)
Nguyen Duy Phong (378051)
Nguyen Thi Dung (245054)
Ly Van Chuong (342084)
Sue J. Lee (140486)
M. Caws (378052)
Menno D. de Jong (186860)
Tran Tinh Hien (74675)
Jeremy J. Farrar (74269)

February 2013

a) survival curve for all patients. b) survival curve stratified according to TBM grade</p

Kaplan-Meier plot of time to antiretroviral treatment initiation for HIV infected rifampicin resistant tuberculosis patients.

Johnny Flippie Daniels (824444)
Mohammed Khogali (550243)
Erika Mohr (3331566)
Vivian Cox (487001)
Sizulu Moyo (23102)
Mary Edginton (305166)
Sven Gudmund Hinderaker (305161)
Graeme Meintjes (221054)
Jennifer Hughes (384435)
Virginia De Azevedo (129372)
Gilles van Cutsem (93995)
Helen Suzanne Cox (824445)

November 2015

Kaplan-Meier plot of time to antiretroviral treatment initiation for HIV infected rifampicin resi...

Kaplan-Meier survival curve for the impact of lopinavir/ritonavir dosing strategy among patients with HIV/TB coinfection on time until treatment discontinuation.

Richard A. Murphy (304728)
Vincent C. Marconi (220305)
Rajesh T. Gandhi (244028)
Daniel R. Kuritzkes (214840)
Henry Sunpath (298135)

February 2013

Kaplan-Meier survival curve for the impact of lopinavir/ritonavir dosing strategy among patients ...

Kaplan-Meier survival curve* of the proportion of patients attending public HIV treatment facilities in Brazil (n = 463) between January 1, 1995 and December 31, 2001 who remained TB free at primary study endpoint (i.e., TB, death, or last clinic visit) over the time course (in days) of the study period, by intervention (HAART, ART non-HAART), and non-intervention (ART naïve).

Abraham Miranda (378672)
Meade Morgan (378673)
Leda Jamal (378674)
Kayla Laserson (287607)
Draurio Barreira (328742)
Guida Silva (378675)
Joseney Santos (378676)
Charles Wells (378677)
Patricia Paine (378678)
Denise Garrett (378679)

February 2013

Kaplan-Meier survival curve* of the proportion of patients attending public HIV treatment facilit...

Kaplan Meier survival curve among HIV patients treated by ART alone versus INH plus ART.

Dumessa Edessa (792901)
Jimma Likisa (792902)

September 2015

Kaplan Meier survival curve among HIV patients treated by ART alone versus INH plus ART.</p

Kaplan-Meier curve of HIV-infected patients who developed active tuberculosis disease by interferon-gamma release assay (IGRA) status, excluding 31 subjects with indeterminate results (N = 741).

Susan Shin-Jung Lee (784202)
Hsi-Hsun Lin (473561)
Hung-Chin Tsai (673178)
Ih-Jen Su (87501)
Chin-Hui Yang (450823)
Hsin-Yun Sun (61134)
Chien-Chin Hung (784203)
Cheng-Len Sy (784204)
Kuan-Sheng Wu (784205)
Jui-Kuang Chen (784206)
Yao-Shen Chen (139714)
Chi-Tai Fang (125570)

August 2015

Kaplan-Meier curve of HIV-infected patients who developed active tuberculosis disease by interfer...

Kaplan-Meier survival plot of time to initial sputum culture conversion by HIV status.

Agumas Shibabaw (5451668)
Baye Gelaw (3181905)
Shu-Hua Wang (4726611)
Belay Tessema (3181893)

June 2018

Kaplan-Meier survival plot of time to initial sputum culture conversion by HIV status.</p

Kaplan Meier survival estimates among HIV infected individuals who were on ART by CD4 T cell count at the time of initiation of ART (N = 239).

Sandeep Rai (422732)
Bidhubhusan Mahapatra (308531)
Subhashish Sircar (422733)
Pinnamaneni Yujwal Raj (422734)
Srinivasan Venkatesh (347049)
Mohammed Shaukat (422735)
Bharat Bhusan Rewari (422736)

June 2013

Kaplan Meier survival estimates among HIV infected individuals who were on ART by CD4 T cell coun...

Kaplan-Meier curve to development of active tuberculosis disease by composite risk factor combining high HIV viral load of greater than 100,000 copies per mL, CD4 cell count and interferon-gamma release assay (IGRA)(N = 772).

Susan Shin-Jung Lee (784202)
Hsi-Hsun Lin (473561)
Hung-Chin Tsai (673178)
Ih-Jen Su (87501)
Chin-Hui Yang (450823)
Hsin-Yun Sun (61134)
Chien-Chin Hung (784203)
Cheng-Len Sy (784204)
Kuan-Sheng Wu (784205)
Jui-Kuang Chen (784206)
Yao-Shen Chen (139714)
Chi-Tai Fang (125570)

August 2015

Kaplan-Meier curve to development of active tuberculosis disease by composite risk factor combini...

Kaplan-Meier survival curve for time from HIV diagnosis to viral suppression, by baseline CD4 count.

H. Irene Hall (211080)
Tian Tang (66588)
Andrew O. Westfall (186956)
Michael J. Mugavero (503845)

December 2013

Kaplan-Meier survival curve for time from HIV diagnosis to viral suppression, by baseline CD4 cou...

Kaplan-Meier curves indicating estimate cumulative hazard for the development of drug induced liver injury between HIV patients receiving efavirenz based HAART alone and TB-HIV coinfected patients receiving efavirenz based HAART with rifampicin based anti-TB therapy during the first three months of follow up period.

Sabina Mugusi (316245)
Eliford Ngaimisi (316246)
Mohamed Janabi (316247)
Omary Minzi (316248)
Muhammad Bakari (316249)
Klaus-Dieter Riedel (316250)
Juergen Burhenne (316251)
Lars Lindquist (316252)
Ferdinand Mugusi (214835)
Eric Sandstrom (316253)
Eleni Aklillu (316254)

February 2013

Kaplan-Meier curves indicating estimate cumulative hazard for the development of drug induced liv...

Regression Analysis Associated with Survival among XDR-TB patients with HIV-coinfection (n = 129).

Sheela V. Shenoi (330429)
Ralph P. Brooks (330430)
Russell Barbour (330431)
Frederick L. Altice (256777)
Daniel Zelterman (321406)
Anthony P. Moll (330432)
Iqbal Master (330434)
Theo L. van der Merwe (330436)
Gerald H. Friedland (330438)

February 2013

Regression Analysis Associated with Survival among XDR-TB patients with HIV-coinfection (n = 129)...

Kaplan Meier survival estimates among HIV infected individuals who were on ART (N = 239).

Sandeep Rai (422732)
Bidhubhusan Mahapatra (308531)
Subhashish Sircar (422733)
Pinnamaneni Yujwal Raj (422734)
Srinivasan Venkatesh (347049)
Mohammed Shaukat (422735)
Bharat Bhusan Rewari (422736)

June 2013

Kaplan Meier survival estimates among HIV infected individuals who were on ART (N = 239).</p

Kaplan Meier curves of the probability of reaching the different end-points according to the PI/r component of the initial cART regimen in 1362 HIV positive LC patients.

Antonella d’Arminio Monforte (2198545)
Alessandro Cozzi-Lepri (195759)
Franco Maggiolo (372561)
Giuliano Rizzardini (103636)
Paolo Emilio Manconi (3162948)
Nicola Gianotti (3162951)
Tiziana Quirino (3162945)
Carmela Pinnetti (782902)
Stefano Rusconi (237803)
Andrea De Luca (132288)
Andrea Antinori (103654)

June 2016

Kaplan Meier curves of the probability of reaching the different end-points according to the PI/r...

Univariate and multivariate analyses to assess associations with rifampicin resistance among all, previously treated, and HIV positive culture positive TB cases.

Helen S. Cox (80991)
Cheryl McDermid (335960)
Virginia Azevedo (335962)
Odelia Muller (359842)
David Coetzee (129367)
John Simpson (359843)
Marinus Barnard (359844)
Gerrit Coetzee (296078)
Gilles van Cutsem (93995)
Eric Goemaere (129370)

February 2013

Univariate and multivariate analyses to assess associations with rifampicin resistance among all,...

Kaplan-Meier survival estimate for HIV-associated TBM patients.

M. Estee Torok (5653990)
Tran Thi Hong Chau (81615)
Pham Phuong Mai (378050)
Nguyen Duy Phong (378051)
Nguyen Thi Dung (245054)
Ly Van Chuong (342084)
Sue J. Lee (140486)
M. Caws (378052)
Menno D. de Jong (186860)
Tran Tinh Hien (74675)
Jeremy J. Farrar (74269)

February 2013

a) survival curve for all patients. b) survival curve stratified according to TBM grade</p

Kaplan-Meier plot of time to antiretroviral treatment initiation for HIV infected rifampicin resistant tuberculosis patients.

Johnny Flippie Daniels (824444)
Mohammed Khogali (550243)
Erika Mohr (3331566)
Vivian Cox (487001)
Sizulu Moyo (23102)
Mary Edginton (305166)
Sven Gudmund Hinderaker (305161)
Graeme Meintjes (221054)
Jennifer Hughes (384435)
Virginia De Azevedo (129372)
Gilles van Cutsem (93995)
Helen Suzanne Cox (824445)

November 2015

Kaplan-Meier plot of time to antiretroviral treatment initiation for HIV infected rifampicin resi...

Kaplan-Meier survival curve for the impact of lopinavir/ritonavir dosing strategy among patients with HIV/TB coinfection on time until treatment discontinuation.

Richard A. Murphy (304728)
Vincent C. Marconi (220305)
Rajesh T. Gandhi (244028)
Daniel R. Kuritzkes (214840)
Henry Sunpath (298135)

February 2013

Kaplan-Meier survival curve for the impact of lopinavir/ritonavir dosing strategy among patients ...

Kaplan-Meier survival curve* of the proportion of patients attending public HIV treatment facilities in Brazil (n = 463) between January 1, 1995 and December 31, 2001 who remained TB free at primary study endpoint (i.e., TB, death, or last clinic visit) over the time course (in days) of the study period, by intervention (HAART, ART non-HAART), and non-intervention (ART naïve).

Abraham Miranda (378672)
Meade Morgan (378673)
Leda Jamal (378674)
Kayla Laserson (287607)
Draurio Barreira (328742)
Guida Silva (378675)
Joseney Santos (378676)
Charles Wells (378677)
Patricia Paine (378678)
Denise Garrett (378679)

February 2013

Kaplan-Meier survival curve* of the proportion of patients attending public HIV treatment facilit...

Kaplan Meier survival curve among HIV patients treated by ART alone versus INH plus ART.

Dumessa Edessa (792901)
Jimma Likisa (792902)

September 2015

Kaplan Meier survival curve among HIV patients treated by ART alone versus INH plus ART.</p

Kaplan-Meier curve of HIV-infected patients who developed active tuberculosis disease by interferon-gamma release assay (IGRA) status, excluding 31 subjects with indeterminate results (N = 741).

Susan Shin-Jung Lee (784202)
Hsi-Hsun Lin (473561)
Hung-Chin Tsai (673178)
Ih-Jen Su (87501)
Chin-Hui Yang (450823)
Hsin-Yun Sun (61134)
Chien-Chin Hung (784203)
Cheng-Len Sy (784204)
Kuan-Sheng Wu (784205)
Jui-Kuang Chen (784206)
Yao-Shen Chen (139714)
Chi-Tai Fang (125570)

August 2015

Kaplan-Meier curve of HIV-infected patients who developed active tuberculosis disease by interfer...

Kaplan-Meier survival plot of time to initial sputum culture conversion by HIV status.

Agumas Shibabaw (5451668)
Baye Gelaw (3181905)
Shu-Hua Wang (4726611)
Belay Tessema (3181893)

June 2018

Kaplan-Meier survival plot of time to initial sputum culture conversion by HIV status.</p

Kaplan Meier survival estimates among HIV infected individuals who were on ART by CD4 T cell count at the time of initiation of ART (N = 239).

Sandeep Rai (422732)
Bidhubhusan Mahapatra (308531)
Subhashish Sircar (422733)
Pinnamaneni Yujwal Raj (422734)
Srinivasan Venkatesh (347049)
Mohammed Shaukat (422735)
Bharat Bhusan Rewari (422736)

June 2013

Kaplan Meier survival estimates among HIV infected individuals who were on ART by CD4 T cell coun...

Kaplan-Meier curve to development of active tuberculosis disease by composite risk factor combining high HIV viral load of greater than 100,000 copies per mL, CD4 cell count and interferon-gamma release assay (IGRA)(N = 772).

Susan Shin-Jung Lee (784202)
Hsi-Hsun Lin (473561)
Hung-Chin Tsai (673178)
Ih-Jen Su (87501)
Chin-Hui Yang (450823)
Hsin-Yun Sun (61134)
Chien-Chin Hung (784203)
Cheng-Len Sy (784204)
Kuan-Sheng Wu (784205)
Jui-Kuang Chen (784206)
Yao-Shen Chen (139714)
Chi-Tai Fang (125570)

August 2015

Kaplan-Meier curve to development of active tuberculosis disease by composite risk factor combini...

Kaplan-Meier survival curve for time from HIV diagnosis to viral suppression, by baseline CD4 count.

H. Irene Hall (211080)
Tian Tang (66588)
Andrew O. Westfall (186956)
Michael J. Mugavero (503845)

December 2013

Kaplan-Meier survival curve for time from HIV diagnosis to viral suppression, by baseline CD4 cou...

Kaplan-Meier curves indicating estimate cumulative hazard for the development of drug induced liver injury between HIV patients receiving efavirenz based HAART alone and TB-HIV coinfected patients receiving efavirenz based HAART with rifampicin based anti-TB therapy during the first three months of follow up period.

Sabina Mugusi (316245)
Eliford Ngaimisi (316246)
Mohamed Janabi (316247)
Omary Minzi (316248)
Muhammad Bakari (316249)
Klaus-Dieter Riedel (316250)
Juergen Burhenne (316251)
Lars Lindquist (316252)
Ferdinand Mugusi (214835)
Eric Sandstrom (316253)
Eleni Aklillu (316254)

February 2013

Kaplan-Meier curves indicating estimate cumulative hazard for the development of drug induced liv...

Regression Analysis Associated with Survival among XDR-TB patients with HIV-coinfection (n = 129).

Sheela V. Shenoi (330429)
Ralph P. Brooks (330430)
Russell Barbour (330431)
Frederick L. Altice (256777)
Daniel Zelterman (321406)
Anthony P. Moll (330432)
Iqbal Master (330434)
Theo L. van der Merwe (330436)
Gerald H. Friedland (330438)

February 2013

Regression Analysis Associated with Survival among XDR-TB patients with HIV-coinfection (n = 129)...

Kaplan Meier survival estimates among HIV infected individuals who were on ART (N = 239).

Sandeep Rai (422732)
Bidhubhusan Mahapatra (308531)
Subhashish Sircar (422733)
Pinnamaneni Yujwal Raj (422734)
Srinivasan Venkatesh (347049)
Mohammed Shaukat (422735)
Bharat Bhusan Rewari (422736)

June 2013

Kaplan Meier survival estimates among HIV infected individuals who were on ART (N = 239).</p

Kaplan Meier curves of the probability of reaching the different end-points according to the PI/r component of the initial cART regimen in 1362 HIV positive LC patients.

Antonella d’Arminio Monforte (2198545)
Alessandro Cozzi-Lepri (195759)
Franco Maggiolo (372561)
Giuliano Rizzardini (103636)
Paolo Emilio Manconi (3162948)
Nicola Gianotti (3162951)
Tiziana Quirino (3162945)
Carmela Pinnetti (782902)
Stefano Rusconi (237803)
Andrea De Luca (132288)
Andrea Antinori (103654)

June 2016

Kaplan Meier curves of the probability of reaching the different end-points according to the PI/r...

Univariate and multivariate analyses to assess associations with rifampicin resistance among all, previously treated, and HIV positive culture positive TB cases.

Helen S. Cox (80991)
Cheryl McDermid (335960)
Virginia Azevedo (335962)
Odelia Muller (359842)
David Coetzee (129367)
John Simpson (359843)
Marinus Barnard (359844)
Gerrit Coetzee (296078)
Gilles van Cutsem (93995)
Eric Goemaere (129370)

February 2013

Univariate and multivariate analyses to assess associations with rifampicin resistance among all,...

Kaplan-Meier survival estimate for HIV-associated TBM patients.

M. Estee Torok (5653990)
Tran Thi Hong Chau (81615)
Pham Phuong Mai (378050)
Nguyen Duy Phong (378051)
Nguyen Thi Dung (245054)
Ly Van Chuong (342084)
Sue J. Lee (140486)
M. Caws (378052)
Menno D. de Jong (186860)
Tran Tinh Hien (74675)
Jeremy J. Farrar (74269)

February 2013

a) survival curve for all patients. b) survival curve stratified according to TBM grade</p

Kaplan-Meier plot of survival during treatment of rifampicin resistant tuberculosis by ART initiation, from multivariate Cox regression analysis for HIV co-infected patients.

Abstract

Extracted data

Kaplan-Meier plot of survival during treatment of rifampicin resistant tuberculosis by ART initiation, from multivariate Cox regression analysis for HIV co-infected patients.

Abstract

Extracted data

Related items

Related items